A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. Earlier this year, Caremark revealed that it would remove Eli Lilly's blockbuster drug ...
California judge says lawsuit can't proceed as a class action Another judge had certified a class of 6,000 workers Multiple cases claim Black workers faced harassment Nov 17 (Reuters) - A California ...
A class action lawsuit has been filed against CVS Caremark (NYSE:CVS), the pharmacy benefit manager for health insurer Aetna, after it dropped Eli Lilly's (NYSE:LLY) weight loss med Zepbound ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results